Circulating Tumor Cells: How Far Have We Come with Mining These Seeds of Metastasis?
Article in Cancers (February 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX
Article in Cancers (February 2021)
Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients
Article in Cells (June 2019)